Drug Database
J07 VACCINES
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- J07AE01 cholera, inactivated, whole cell
- J07AE02 cholera, live attenuated
- J07AG53 haemophilus influenzae B, combinations with meningococcus C, conjugated
- J07AH08 meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
- J07AH09 meningococcus B, multicomponent vaccine
- J07AJ52 pertussis, purified antigen, combinations with toxoids
- J07AL01 pneumococcus, purified polysaccharides antigen
- J07AL02 pneumococcus, purified polysaccharides antigen conjugated
- J07AL52 pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated
- J07AN01 tuberculosis, live attenuated
- J07AP01 typhoid, oral, live attenuated
- J07AP03 typhoid, purified polysaccharide antigen
- J07BA01 encephalitis, tick borne, inactivated, whole virus
- J07BA02 encephalitis, Japanese, inactivated, whole virus
- J07BB01 influenza, inactivated, whole virus
- J07BB02 influenza, inactivated, split virus or surface antigen
- J07BB03 influenza, live attenuated
- J07BC01 hepatitis B, purified antigen
- J07BC02 hepatitis A, inactivated, whole virus
- J07BC20 combinations
- J07BD52 measles, combinations with mumps and rubella, live attenuated
- J07BG01 rabies, inactivated, whole virus
- J07BH01 rota virus, live attenuated
- J07BK01 varicella, live attenuated
- J07BK02 zoster, live attenuated
- J07BK03 zoster, purified antigen
- J07BL01 yellow fever, live attenuated
- J07BM01 papillomavirus (human types 6, 11, 16, 18)
- J07BM02 papillomavirus (human types 16, 18)
- J07BM03 papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)
- J07BN01 covid-19, RNA-based vaccine
- J07BN04 covid-19, protein subunit
- J07BX04 dengue virus vaccines
- J07BX05 Respiratory syncytial virus vaccines
- J07CA01 diphtheria-poliomyelitis-tetanus
- J07CA02 diphtheria-pertussis-poliomyelitis-tetanus
- J07CA06 diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus
- J07CA09 diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B
- J07CA10 typhoid-hepatitis A
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).